Abstract: Excessive dexamethasone (Dex) administrated into pregnant mice during critical periods of palatal development can produce a high incidence of cleft palate. Its mechanisms remain unknown. Vitamin B 12 has been shown to antagonize the teratogenic effects of Dex, which, however, remains controversial. In this study, we investigated the effects of Dex and vitamin B 12 on murine embryonic palatal shelf fusion using organ culture of murine embryonic shelves. The explanted palatal shelves on embryonic day 14 (E14) were cultured for 24, 48, 72 or 96 h in different concentrations of Dex and/or vitamin B 12 . The palatal shelves were examined histologically for the morphological alterations on the medial edge epithelium (MEE) and fusion rates among different groups. It was found that the palatal shelves were not fused at 72 h or less of culture in Dex group, while they were completely fused in the control and vitamin B 12 -treated groups at 72 and 96 h, respectively. The MEE still existed and proliferated. In Dex+vitamin B 12 group the palatal shelves were fused at each time point in a similar rate to controls. These results may suggest that Dex causes teratogenesis of murine embryonic palatal shelves and vitamin B 12 prevents the teratogenic effect of Dex on palatogenesis on murine embryos in vitro.
INTRODUCTION
Cleft lip and palate is one of the most frequent congenital malformations in humans. Its etiology is complex and multifactorial. Both genetic and environmental factors are involved and regulated spatially and temporally by complicated molecular mechanisms (Gritli-Linde, 2007; Rice, 2005) . The formation of the mammalian secondary palate requires several critical steps, including growth, elevation, contact, medial edge epithelium (MEE) disappearance, and, finally, bilateral palatal shelves fusion. Interruption of any of these steps may cause cleft palate.
B-vitamins are a group of water-soluble vitamins, including B 6 , B 12 , folic acid, etc. Deficiency of vitamins is associated with many illness and birth defects (Botto et al., 2004; Herrmann et al., 2007; Krapels et al., 2004) . Epidemiological studies of cleft lip and palate showed that a pregnant female taking certain doses of vitamin B 12 may decrease the incidence of cleft and palate in her offspring (van Rooij et al., 2003) . However, others also reported that children with congenital malformations did not show any serum vitamin deficiencies compared with a normal population (Stoll et al., 1999) . It was reported that palatal development in vitro was similar to in vivo (Koch and Smiley, 1981; Shimizu et al., 2001) . In this study we have investigated the teratogenic effect of dexamethasone (Dex) on the palate and employed vitamin B 12 to antagonize the teratogenic effects of Dex on palate fusion in mouse (Hassell, 1975) .
MATERIALS AND METHODS

Animals
Adult C57BL/6J mice, weighting 15~20 g, one male and two females per cage, were mated overnight in a temperature-controlled (22 °C) SPF (specified-pathogens free) room, water and food ad libitum. Vaginal plugs appeared in the following morning, which was designated as the embryonic day 0 (E0).
Dissection and organ culture
On E14, mouse embryos were quickly immersed in GMF-PBS (Ca 2+ and Mg 2+ free-phosphate buffed solution, pH 7.2) and flushed lightly several times. Then the palatal shelves were removed using microsurgical shears and forceps under a dissecting microscope. Isolated palatal shelves were cultured according to the previous methods (Hassell, 1975) . Briefly, the palatal shelves were placed in pairs on 0.4 μm porosity millipore filters (Millipore Corporation, USA), nasal epithelium down, media edges in contact, on 35 mm-tissue culture dishes (FALCON, France). The culture medium was composed of DMEM/F12 (Dulbecco's modified Eagle's medium/nutrient mixture F-12 Ham's) (Hyclone Corporation, USA), 10% fetal bovine serum (FBS, Hyclone Corporation), and 100 U/ml Penicillin-Streptomycin, with or without 20 ng/ml Dex (Sigma, USA) and/or 10 ng/ml vitamin B 12 (Sigma, USA). Transplants were divided into the control, the Dex-treated, the vitamin B 12 -treated, and the Dex+ vitamin B 12 -treated groups, with 8 samples in each group. Samples were cultured for 24, 48, 72 or 96 h at 37 °C in an incubator with 5% CO 2 (Leica, Germany). All the medium and treatments were replaced every 24 h.
Histology
At the end of incubation, transplants were immediately immersed in 4% neutral paraformaldehyde and embedded in paraffin. Then, 5 μm-thick serial sections were cut and stained with eosin and haematoxylin. These sections were then photographed using a Leica photographic system (Germany).
Scanning electron microscopy (SEM) preparation
Transplants were immersed in 2.5% glutaraldehyde solution for 2 h at room temperature, and then followed were ethanol gradient dehydration, isoamylacetate replacement, critical point drying, and gold plating. At last, the samples were scanned to observe surface changes of the palatal shelves.
Statistical analysis
Statistical analysis was performed with the chi-square test and variance analysis (SPSS 13.0). Different groups in the same designated time and in the same group across different incubation times were compared. Values of P<0.05 were considered significant.
RESULTS
The numbers of palatal shelf fusion in various experimental groups are presented in Table 1 . The palatal shelves were not fused at the 72 h or less of culture in Dex group, compared with controls (P<0.0025), indicating the teratogenesis of Dex. In Dex+vitamin B 12 group the palatal shelves were fused at each time point in a similar rate to the control and vitamin B 12 groups, significantly different from the Dex group (P<0.05). These results indicate the antagonistic effect of vitamin B 12 against Dex.
Light microscope
Transplants were classified in three groups according to Vargas (1967) method: no fusion, partial fusion, and complete fusion. Complete fusion or mesenchymal coalescence means no MEE is observed, and the epithelial laminae have been broken down and resorbed. All of the palates in the control group completely fused after 48 h (Fig.1b) , and no MEE was observed. All of the palates in the vitamin B 12 -treated group also completely fused at 96 h. There was no significant difference between control and vitamin B 12 -treated groups (P>0.5) after 48, 72 and 96 h, which suggests that vitamin B 12 had no effect on normal palatal fusion (Figs.1e and 1f ). In the Dex-treated group at 24 h no fusion was observed (Fig.1c ) and the MEE existed; at 48 h only 1 out of 8 ( Fig.1d) and at 72 h 2 out of 8 fused (Fig.1g) , and MEE did not disappear but thickened. In Dex+vitamin B 12 group at 24 (Fig.1g) , 48 ( Fig.1h ), 72 and 96 h, 5, 6, 7 and 7 out of 8 samples fused, respectively, indicating the antagonism of vitamin B 12 against Dex.
Scanning electron microscopy
Figs.2a and 2b showed situation of the palatal shelves in the control group, and incubated after 24 h, bilateral palatal shelves have achieved completely fusion. The spheroidal structures in MES (medial epithelial seam) seemed likely deciduous perithelial cells from MEE and migrated to surface. The observations of palatal shelves of Dex-treated group showed in Figs.2c and 2d . Opposing palatal shelves seemed fused incompletely and retained seam between bilateral palates. The spheroidal structures in MES and palatal surface were less than the control group, and the spheroidal structures trapped, which suggested perithelial cells that underwent slough and migration were less than the control group. The perithelial cells did not slough and migrate, which resulted in basal cell of MEE and could not contact and induced cleft palate. Some fibroblast-like cells were observed on the surface of palatal shelves after vitamin B 12 treatment (Figs.2e and 2f ), but fusion of shelves was normal (Fig.2g) . Possibly, function of vitamin B 12 involved in cell morphous was needed further study. In vitamin B 12 +Dex-treated group, surface morphous of palatal shelves was similar to that of the control group, and bilateral shelves fused but retained some feature like vitamin B 12 -treated group (Figs.2h, 2i and 2j) .
Fig.1 Hematoxylin and eosin (H & E)-stained sections of the palatal shelves. In the control group at 24 h of culture (a), the MEE was observed, and at 48 h (b), the MEE disappeared and the bilateral palatal shelves fused. In Dex group at 24 h (c) and 48 h (d), the MEE was still seen and after 48 h the MEE thickened. In vitamin B 12 -treated group at 24 h (e) and 48 h (f), the MEE also disappeared. In Dex+vitamin B 12 group at 24 h (g) and 48 h (h) the bilateral palatal shelves fused
Black arrows show the MEE; Scale bars=50 µm DISCUSSION Bilateral palatal fusion includes two phases: the first phase in which palates move from a vertical position to a horizontal position, and the second phase in which the two palates contact and fuse to form the secondary palate. The potential of the palatal shelves to fuse in vitro depends on the age of embryo, which varies among species. Pourtois (1966) found that in the rat the potential to fuse was acquired 24 h before the actual time of the secondary palatal fusion, whereas Vargas (1967) found that in the mouse it was at least 40 h before the actual time of fusion in vivo. Teratogens that disturb any of these developmental 
events may induce a failure of the palates to fuse. Studies both in vivo and in vitro demonstrated that environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a cleft palate teratogen, not only disrupts the differentiation and proliferation of the bilateral MEE in mice, but also has effects on the expression of some growth factors (Abbott and Birnbaum, 1990a; 1990b; Abbott et al., 1989a; 1992; 2005b; Bock and Köhle, 2006; Hassoun and Dencker, 1982; Miettinen et al., 2004; Ryan et al., 1989) . Other teratogens also showed effects on the fusion of the palatal shelves, such as retinoic acid (RA), which induces cleft palate when administered in excess to the maternal mouse, depending on the stage of embryonic development exposed (Abbott et al., 1989b; Newall and Edwards, 1981) . Both in vivo and in vitro studies showed that RA changed the regulation of cell proliferation, which was often associated with the altered expression of epidermal growth factor receptor (EGFR) (Abbott and Birnbaum, 1990c; Abbott et al., 2005a) and transforming growth factor beta (TGF-β) (Degitz et al., 1998; Nugent et al., 1998) . Dex, one of the glucocorticoids (GC) that are well-known teratogens, is a fat-soluble hormone that penetrates the cell membrane and binds to GC receptor (GR) in the cytoplasm, inhibiting palatal mesenchymal proliferation, and resulting in smaller palates that fail to contact and fuse (Greene and Kochhar, 1975; Hackney, 1980; Pratt et al., 1984; Shah et al., 1989) . Sensitivity to Dex varies by species and stages of pregnancy, and the species differences in susceptibility are related to H-2 histocompatility (Kusanagi, 1984; Montenegro and Palomino, 1989) . A population-based case-control study of cleft lip and palate showed that maternal corticosteroid use during pregnancy is associated with moderately increased risk of delivering an infant with an orofacial cleft (Carmichael et al., 2007) .
Various in vitro methods have been employed in the investigation on the effects of Dex on the palate, including mesenchymal culture, or palatal epithelial and mesenchymal co-incubation, and organ culture. The methods vary in their ability to stimulate palate development and fusion, and the organ culture has significant advantages in this regard (Chou et al., 2004) . In the current study, we observed that Dex appeared to stimulate the thickening of the MEE. When exposed to 20 ng/ml Dex for 24 h, the palatal shelves from E14 pregnant mice retained the MEE, and even after 96 h the MEE still existed. SEM images show that the spheroidal structures did not disappear and seemed trapped in the medial edge seam. Compared with the control group, few filopodia were observed.
Vitamin B 12 is one of the most important coenzymes and participates in many biochemical reactions in vivo (Selhub, 2002) . Population-based epidemiological investigations showed that pregnant women taking certain doses of vitamin B 12 could reduce the risk of non-syndromic craniofacial clefts (van Rooij et al., 2003; Vujkovic et al., 2007) . It was demonstrated that the vitamin B 12 concentration of 185 pmol/L or less and the pyridoxal-5′-phosphate (PLP) concentration of 44 nmol/L or less in mothers increased the risk of having a child with cleft lip with or without cleft palate (van Rooij et al., 2003) . Animal experiments showed that when vitamin B 12 level decreased, the level of amniotic homocysteine, a risk factor for the malformation of the palate, increased (Weingärtner et al., 2007) . Experiments on mice from E10~E13 demonstrated that vitamin B 12 could antagonize the Dex-induced cleft palate (Natsume et al., 1986) . However, the main mechanism of how vitamin B 12 antagonized the Dex-induced craniofacial clefts is still unknown.
In the current studies, in the vitamin B 12 -treated group 10 ng/ml vitamin B 12 was added in the medium, and the palate fuse rate and SEM images were similar to the control, suggesting that vitamin B 12 had no effect on palatal MEE. With exposure to 20 ng/ml Dex+10 ng/ml vitamin B 12 , at 48 h incubation, the fuse rate significantly increased to near the one in controls and SEM images became similar to the control as well. These results demonstrate that vitamin B 12 could antagonize the Dex-induced failure of the palatal fusion in mouse embryos.
CONCLUSION
In summary, our results may suggest that Dex causes teratogenesis of murine embryonic palatal shelves and vitamin B 12 prevents the teratogenic effect of Dex on palatogenesis on murine embryos in vitro. We, therefore, propose that a proper concentration of vitamin B 12 may effectively antagonize the effects of Dex that leads to MEE thickening, which is possibly a consequence of excessive MEE proliferation or reduced cell death. Investigations into the molecular mechanisms of how Dex interacted with vitamin B 12 were not examined and further studies are needed to clarify the preventive effects of vitamin B 12 on cleft lip and palate.
